-
Brexit, new technology and communication
Pharma Integrates covers the most important issues currently facing the pharmaceutical industry Last week, another successful Pharma Integrates saw more than 350 key industry leaders converge in London to discuss the most critical considerations for the pharmaceutical industry in these uncertain times. The sessions tackled some difficult topics, such as the implications of Brexit for the pharmaceutical…
-
Congratulations to Sciad Communications’ clients – 2018 in Review
Congratulations to all our clients on another successful year. Here are some of our news highlights – Bring on 2019! Awards Several of our clients have been recognised this year for their progress and contributions to their respective industries. Check4Cancer Diagnostics provider of the year – Health Investor Awards Domainex Fastest growing CRO in Europe…
-
Check4Cancer launches innovative prostate cancer diagnosis pathway with AXA PPP healthcare
Prostate cancer is the most common cancer in men, with 1 in 8 diagnosed at some point in their lives.1 Indeed, with Men’s Health Awareness Month underway, the importance of tackling this prevalent disease is, quite rightly, capturing public attention. Cambridge, UK, 27th November 2018 / Sciad Newswire / Traditionally, the diagnosis of prostate cancer has involved…
-
Solentim wins place in Deloitte UK Technology Fast 50
Solentim named as one of the top 50 fastest growing UK technologies companies of 2018 Wimborne, UK, 16th November 2018 / Sciad Newswire / Solentim, a life sciences company, has won a place in this year’s Deloitte’s UK Technology Fast 50 list following a 1,106% revenue growth over the past 4 years. Solentim specialises in products used…
-
Synpromics named among the top 50 fastest growing technology companies in the UK
Synpromics 12th in the Deloitte UK Technology Fast 5 Edinburgh, UK, 16th November 2018 / Synpromics, the leader in gene control, is delighted to announce that it has been ranked 12th in the Deloitte ‘UK Technology Fast 50’ at the annual awards ceremony in London last night. The Deloitte Technology Fast 50 is one of the UK’s…
-
Pharma Integrates brings key opinion leaders together to shape the future of healthcare
London, UK, 15th November 2018 / Sciad Newswire / Pharma Integrates 2018, which took place earlier this week, attracted more than 350 key industry experts to discuss, debate and share insights on critical challenges in the pharmaceutical industry. After the great success of last year, the event moved to a larger venue at the Grange Tower Bridge Hotel,…
-
Medherant announces positive Phase I results for its first transdermal drug delivery patch
Coventry, UK, 5th November 2018 / Sciad Newswire / Medherant, a developer of innovative transdermal drug delivery treatments for pain and CNS diseases, has successfully completed two Phase I studies with its novel Ibuprofen TEPI® Patch. The TEPI Patch was shown to be well tolerated by all subjects in a study of skin irritation and sensitisation. This marks…
-
Synpromics Promoter Technology Moves Closer to the Clinic
Edinburgh, UK, 18th October 2018 / Sciad Newswire / Synpromics is pleased to announce positive data presented today by a key partner, uniQure (NASDAQ:QURE), at the European Society of Gene and Cell Therapy conference in Lausanne, Switzerland. The study used uniQure’s next-generation liver-directed gene therapy system that incorporates a short, highly-selective and powerful liver promoter that was developed by Synpromics. The…
-
Synpromics Unveils Next Generation Liver Selective and Tunable Promoter Platform
Edinburgh, UK, 17th October 2018 / Sciad Newswire / Synpromics is today unveiling its novel drug-regulatable promoter platform at the European Society of Cell and Gene Therapy (ESGCT) congress in Lausanne, Switzerland. The company is showcasing data generated from its innovative liver selective inducible and repressible synthetic promoter systems that are tightly controlled by FDA-approved small molecule drugs. Synpromics has…
-
Evonetix wins Best Emerging Synthetic Biology Company at the OBN Awards
London, UK, 12th October 2018 / Sciad Newswire / SynbiCITE would like to congratulate Evonetix on winning ‘Best Emerging Synthetic Biology Company’ at the 10th Annual OBN Awards Ceremony last night. The award recognises the emerging UK industrial or synthetic biology company that demonstrates the most promise. Entrants were assessed on capital raised, level of innovation and their contribution to the…